目的 評價復方蟬花片對2型糖尿病患者的治療作用及安全性評價。方法 選擇中國人民解放軍第二四五醫(yī)院血糖偏高的成年2型糖尿病患者109例，隨機分為2組，對照組（n=54）采用常規(guī)治療，治療組（n=55）在常規(guī)治療基礎上口服復方蟬花片2片/次、2次/d，服用量2.4 g/d，連續(xù)服用2個月，評價其療效與安全性。結果 兩組治療前空腹血糖、餐后2 h血糖、尿糖比較無差異。治療后，兩組空腹血糖、尿糖均較治療前降低，治療組餐后2 h血糖降低；治療組空腹血糖降低率（13.50±6.71）%與對照組比較差異顯著（P<0.01）、餐后2 h血糖降低率（13.85±8.74）%，與對照組比較差異顯著（P<0.01）；治療組尿糖積分下降率72.2%，對照組尿糖積分下降率10.52%，兩組比較差異有顯著性（P<0.001）；且兩組無不良反應發(fā)生。結論 復方蟬花片對于2型糖尿病患者具有治療作用，且比較安全，值得推廣應用及深入開發(fā)。

Objective To evaluate the clinical effect and safety of Compound Cicada Flower Tablets on patients with type 2 diabetes Methods One hundrend and nine patients with type 2 diabetes mellitus (DM) who had high blood glucose in the 245th Hospital of the Chinese People's Liberation Army were randomly divided into 2 groups. The control group (n=54) received conventional treatment and treatment group (n=55) received onventional treatment and oral administration Compound Cicada Flower Tablets 2 tablets/times, 2 times/d, taking a dose of 2.4 g/d, and taking it continuously for 2 months to evaluate its efficacy and safety. Results There was no difference in fasting blood glucose, blood glucose 2 h after meal, and urine glucose between two groups. After treatment, the fasting blood glucose and urine glucose of two groups were lower than those of before treatment, and the blood glucose 2 h after meal of ttreatment group was lowered. The freduction rate of asting blood glucose in treatment group was (13.50±6.71)%, significantly different from the control group (P<0.01), and the reduction rate of blood glucose 2 h after meal in treatment group was (13.85±8.74)%, significantly different from ontrol group (P<0.01). The decrease rate of urine glucose score in the treatment group and the control group were 72.2% and 10.52%, respectively and there was a significant difference between the two groups (P<0.001); and no adverse reactions occurred in the two groups. Conclusion The Compound Cicada Flower Tablet is an clinical therapy for patients with type 2 diabetes, and it is safer, and it is worthy of promotion and further development.

R977

國家星火計劃（2015GA700011）